[Incidence of malignant neoplasms in patients with multiple sclerosis]
- PMID: 3614521
[Incidence of malignant neoplasms in patients with multiple sclerosis]
Abstract
The incidence of malignant neoplasma was determined in patients with multiple sclerosis in epidemiological studies in 717 patients. No significant difference was found from the general population aged over 15 years. This seems to suggest that immunosuppression resulting from corticotherapy has no effect increasing the risk of malignant neoplasm development in multiple sclerosis.
Similar articles
-
[Multiple sclerosis mortality in Poland].Neurol Neurochir Pol. 1986 Sep-Oct;20(5):444-7. Neurol Neurochir Pol. 1986. PMID: 3587514 Polish.
-
Cancer risk in multiple sclerosis: findings from British Columbia, Canada.Brain. 2012 Oct;135(Pt 10):2973-9. doi: 10.1093/brain/aws148. Epub 2012 Jun 21. Brain. 2012. PMID: 22730559
-
Primary optic neuritis evolved in multiple sclerosis: an epidemiological study.Acta Neurol (Napoli). 1993 Dec;15(6):433-41. Acta Neurol (Napoli). 1993. PMID: 8160555
-
Osteoporosis in multiple sclerosis.Mult Scler. 2010 Sep;16(9):1031-43. doi: 10.1177/1352458510368985. Epub 2010 Jun 15. Mult Scler. 2010. PMID: 20551086 Review.
-
Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments.Breast Cancer Res Treat. 2005 Feb;89(3):265-70. doi: 10.1007/s10549-004-2229-4. Breast Cancer Res Treat. 2005. PMID: 15754125 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical